show episodes
 
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
  continue reading
 
I'm a Fractional Chief Marketing Officer for life science companies and I help them accelerate product adoption & make marketing work. This is LifeSci Continuum, where we explore the unbroken sequence of innovation, strategy, & growth in the life sciences industry. Join us as we explore the insights and experiences of founders, product managers, commercialization leaders, & marketing pros in the field. Discover the strategies & tactics that have worked for them, hear about their challenges a ...
  continue reading
 
Artwork

1
Persistent Curiosity

Joanna Kaniewska, T Shaped

Unsubscribe
Unsubscribe
Monthly
 
Joanna Kaniewska from T Shaped uncovers career planning strategies for STEM professionals, helping you grow and shape a career that aligns with your goals and passion. Discover what accomplished scientists, engineers, and innovators have done to reach their current positions and learn about their paths to leadership. Through success stories and challenges faced, see how passion can be channeled into fulfilling careers. It features exclusive interviews, invaluable career planning tips, and ke ...
  continue reading
 
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
  continue reading
 
Artwork
 
Welcome to the podcast where the genuine stories of guests take center stage, offering insights into the people behind the science, their journeys, and aspirations. Uncovering the Trials and Errors. I'm Kasia Kuzmicz-Kowalska, a recent PhD graduate, driven by a passion for both science and storytelling. Join me and my guests on a journey Beyond Academia. Expect a candid exchange of experiences, invaluable advice and a deep dive into the advantages and challenges of various career paths. Allo ...
  continue reading
 
Loading …
show series
 
Small and emerging biotech companies have varied challenges compared to mid-large size pharma companies, with paths that aren’t always as straightforward as taking a compound through clinical development to launch. Our biotech clients drive towards these key inflection points from proof of concept to compound development, to capital raises based on…
  continue reading
 
When does a biotech need a Chief Medical Officer? "If you're asking, you probably needed one yesterday," suggests Dr. Benit Maru in this straight-talking episode of Emerging Biotech Leader. The SSI Strategy medical lead breaks from convention, arguing that early-stage organizations - particularly those in rare disease or novel modalities - can't af…
  continue reading
 
Have you ever wondered what makes a great biotech CMO? In this episode of the Emerging Biotech Leader, Dr. Steven Zelenkofske shares the practical, hard-earned insights he’s gained from his five CMO positions and multiple board roles, offering straightforward advice on how CMOs can step in early, build strong executive relationships, and drive clin…
  continue reading
 
Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Follow Glenn: https://www.linkedin.com/in/glenn-hanner-632291a/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 In this episode of LifeSci Continuum, I'm thrilled to reconnect with Glenn…
  continue reading
 
The relationship between biotech leadership and their boards is evolving, particularly as private equity takes a larger role in the industry. In this episode of the Emerging Biotech Leader, Nick Amigone from Amulet Capital Partners offers a unique perspective on building effective board relationships from the private equity vantage point. The conve…
  continue reading
 
How can biotech CEOs and their boards foster strong, trusting relationships that drive effective decision-making and long-term success? In this episode of Emerging Biotech Leader, host Kim Kushner explores this critical question together with Don de Bethizy. Don is a seasoned life sciences executive with over 30 years of experience, having served a…
  continue reading
 
Dr. Andreas Lysandropoulos, Senior Vice President and Global Therapeutic Head of Neurosciences, and Wyatt Gotbetter, Senior Vice President, Worldwide Access Consulting, join Bev Hope, Parexel’s Marketing Strategy Director, in a podcast discussion of how sponsors can build a value proposition and market access strategy for novel neurological and psy…
  continue reading
 
Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Marc: https://www.linkedin.com/in/digitalmktggeek/ This is the chat life science marketing agencies don’t want clients to watch. In…
  continue reading
 
In this episode of "The Emerging Biotech Leader" podcast, host Ramin Frahood speaks with Helen Kargaryani, VP Global Head of Quality/Quality Services at SSI Strategy. With over 30 years of experience in the pharmaceutical and biotech industries, Helen shares her expertise on quality and risk management. Risk management in these industries is a crit…
  continue reading
 
Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Follow Kate: https://www.linkedin.com/in/canadiankate/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 In this episode of LifeSci Continuum, I'm joined again by Kathleen Mitchell as we d…
  continue reading
 
Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Follow Karthik: https://www.linkedin.com/in/kansasbioengineer/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 In this episode of LifeSci Continuum, I'm joined by Karthik Ramachandran, a…
  continue reading
 
De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial succes…
  continue reading
 
De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial succes…
  continue reading
 
This episode offers critical insights on leveraging risk management as a strategic advantage in medical device development. In a conversation with Ramin Farhood, Bijan Elahi, with over 30 years of experience, provides a roadmap for integrating safety considerations into innovation pipelines, potentially accelerating time-to-market and enhancing com…
  continue reading
 
Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 In this episode of LifeSci Continuum, I’m joined by Glenn Hanner, FCMO and experienced marketing leader in the industry to explore how lif…
  continue reading
 
Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Marc: https://www.linkedin.com/in/digitalmktggeek/ About Marc: Marc is a veteran digital marketing and communications professional …
  continue reading
 
Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Kathleen Mitchell: https://www.linkedin.com/in/canadiankate/ About Kathleen: She is a Strategic marketing executive with 20+ years …
  continue reading
 
The latest Emerging Biotech Leader podcast tackles the important topic of patient-focused drug development, offering valuable insights for the biotech industry. Our host Kim Kushner engages in an insightful dialogue with Dr. Laurie Smaldone-Alsup, SVP Regulatory Science at SSI Strategy, who brings years of hands-on regulatory experience to the conv…
  continue reading
 
Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Russ on LinkedIn: https://www.linkedin.com/in/russouellette/ Russ's Podcast: https://www.youtube.com/@RussOuellette @RussOuellette …
  continue reading
 
Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Kate: https://www.linkedin.com/in/katherine-king-french-pmp-b14a7716/ In this episode, I’m joined by Kate French to explore the cri…
  continue reading
 
When it comes to product launches, we tend to hyperfocus on just simply getting everything to launch and we tend to leave the exit strategy to the end. On this episode of LifeSci Continuum, we are joined by David Iannetta as we learn that it is truly never too early to start preparing for your exit. Follow Bill: https://www.linkedin.com/in/foundera…
  continue reading
 
Launching a product is a rollercoaster for product managers and marketers. But jumping in right before the finish line is a different type of ride. In this episode, we are joined by Christi Unger as we discuss her experience launching life-science products and the lessons she learned. Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact …
  continue reading
 
Without two important team traits, your team might be missing their mark. On this week's episode, Kate French joins us to talk about her experience working with engineering and what goes into building effective, high-performing teams in your life sciences company. Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshage…
  continue reading
 
On this episode of Emerging Biotech Leader, Kim Kushner sits down with Edward M Kaye, M.D., CEO and director of Stoke Therapeutics, to talk about his work in rare disease drug development. Throughout their conversation, Ed describes the challenges of first-in-class drug development. He explains the importance of understanding diseases thoroughly an…
  continue reading
 
You might be thinking about highlighting the features and benefits of your medical device. Well, David Iannetta joins us to talk about how looking past the status quo could be the X-Factor for your next Product Launch (or Exit). Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast:…
  continue reading
 
On this episode, we are joined by Jim Dembkoski who is bringing 15 years of product management advice to the table. Join us as we discuss how Jim got into Product Management and the key lessons he learned along the way. Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://…
  continue reading
 
Kicking off the LifeSci Continuum, we are going to cover almost every aspect of Commercialization and product life cycle stage. From Launch to Exit, we go deep with expert interviews, tips, shortcuts, and best practices to help you level up. Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ V…
  continue reading
 
Summary: In this episode, host Kim Kushner is joined by Dr. Chantal van Gils, a leading expert in evidence and value strategy at SSI Strategy. Building on the previous podcast discussion with Christian Howell of Cognito, this episode delves into three key themes:1) differing evidentiary requirements for medical devices versus pharmaceuticals, 2) th…
  continue reading
 
De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial succes…
  continue reading
 
This episode features an interview with Christian Howell, Chief Commercial Officer at Cognito Therapeutics, a biotech company pioneering a neurotechnology approach to treat Alzheimer's disease. Christian draws on his diverse background spanning the military, medical device giant Medtronic, and now the biotech industry. The conversation covers Cogni…
  continue reading
 
The second episode of our ‘Enabling Successful Sites’ series features a discussion between Karen McIntyre (VP, Global Site Alliances), Xoli Belgrave (Sr. Director, Head of Clinical Trial Diversity and Inclusion), Jamie Langley (Executive Director, Parexel Academy) and Dr. Lovie Negrin, CEO and Founder of Randomize now on how we can empower and leve…
  continue reading
 
Oncology clinical trials present unique challenges for investigative sites, including complex trial designs, challenging eligibility criteria, and invasive procedures. In addition, the oversaturation of trials leads to competition for patients and experienced sites. The third episode of Enabling Successful Sites features a discussion between Karen …
  continue reading
 
Episode Overview: In this podcast interview, Ramin Farhood hosts Dr. Thomas Lönngren, an expert in drug regulation, approval, and market access. Thomas has an impressive career spanning over three decades, including a transformative tenure as the executive director of the European Medicines Agency (EMA). He currently serves as a strategic advisor, …
  continue reading
 
De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial succes…
  continue reading
 
In this episode of the Emerging Biotech Leader podcast, hosts Kim Kushner and Ramin Farhood interview Keith Gottesdiener, President and CEO of Prime Medicine. They discuss Keith's unconventional career path, which spans roles as a physician, research scientist, drug development leader at Merck for over 16 years, and entrepreneurial biotech CEO at R…
  continue reading
 
What does a data scientist do? How does the work environment in a start-up contrast with that in academia? What challenges await those who switch scientific disciplines? How to stay involved with the scientific community beyond academia? The typical academic path involves numerous transitions—changing projects, labs, and institutes. Mobility is not…
  continue reading
 
In this engaging episode of the Emerging Biotech Leader podcast, Kim Kushner, Ramin Farhood, and Jackie Levine discuss the key lessons learned from the previous conversation with Dr. Dan Bloomfield, CMO at Anthos Therapeutics. The trio focuses on the challenges biotech companies face when building organizations with evolving goals, the important ro…
  continue reading
 
In this episode of the Emerging Biotech Leader podcast, hosts Kim Kushner and Ramin Farhad speak with Dr. Dan Bloomfield, Chief Medical Officer of Anthos Therapeutics. Dan generously shares insights from his diverse career that has spanned academia at Columbia University, over a decade at big pharma giant Merck across multiple leadership roles, and…
  continue reading
 
What does a CSO of a biotech company do on a day-to-day basis? How much truth lies behind the common stereotypes about working in the biotech industry? What can make you stand out as a candidate for a biotech industry job? Step into the dynamic world of biotech with our latest episode as we debunk common myths and uncover the realities of working i…
  continue reading
 
The site feasibility and initiation process can be a frustrating one for investigative sites due to lengthy questionnaires, duplication in data requests, and unrealistic recruitment targets and start-up timelines. In the first episode of our Enabling Successful Sites podcast Parexel's Karen McIntyre, VP of Global Site Alliances and Marta Leon, VP o…
  continue reading
 
The latest episode of Preparing for a Cell and Gene Future features a discussion between Jamie Pierson (Program Lead within Parexel’s Cell and Gene Center of Excellence) and Kim MacDonnell (Associate Director for Rare Diseases). They consider uses of surrogate markers as endpoints in rare disease development and look ahead to positive directions es…
  continue reading
 
In this third episode on advancing precision oncology, we continue discussing the role of expanding patient access to biomarkers and evolving testing capabilities. Our precision oncology experts delve into the challenges and opportunities that lie ahead in the rapidly changing landscape. They explore advancements in data, machine learning, and test…
  continue reading
 
In this second episode on advancing precision oncology through patient access to biomarkers and testing, the discussion focuses on the benefits of integrating multi-omic data in precision oncology and how it can enhance treatment selection. Our experts discuss the importance of looking beyond genomics and considering other omics, such as immunomics…
  continue reading
 
In this first episode, join our clinical development and market access experts who discuss the role of biomarker research, discovery, and patient access in advancing precision oncology to date. Biomarkers have been central to improving patient outcomes and guiding treatment guidelines in lung, breast, and blood cancers. With that backdrop, our expe…
  continue reading
 
What does a Human Factors Engineer do? What can lead to a decision to exit academia, and what can drive someone to share their transition publicly? What are the do's & don'ts of job hunting? Our guest is Ashley Ruba - an American researcher, currently working as a Human Factors Engineer at Arthrex. Ashley is also a founder of After Academia, a coac…
  continue reading
 
What does the position of Product Manager entail? What makes someone who has a good chance of becoming a PI leave academia? How to deal with imposter syndrome during big career transitions? Our guest is Rose De Guzman - a Filipino-American scientist, currently working as a Product Manager at Evident Scientific. Rose is a passionate advocate for mak…
  continue reading
 
Loading …

Quick Reference Guide